Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 232390, 5 pages
http://dx.doi.org/10.1155/2012/232390
Clinical Study

Heparin Increases HLA-G Levels in Primary Antiphospholipid Syndrome

1Reumatologia Divisão, Faculdade de Medicina, Universidade de São Paulo, Sala 3105, Avenida Dr. Arnaldo, 455, 01246-903 São Paulo, SP, Brazil
2Laboratório Clínico, RDO Diagnósticos, Avenida Brasil 1150, 01430-001 São Paulo, SP, Brazil
3Edocrinologia Divisão, Hospital das Clinicas da Faculdade de Medicina, Universidade de São Paulo, Avenida Dr Enéas de Carvalho Aguiar 44, 05403-000 São Paulo, SP, Brazil

Received 22 December 2011; Revised 3 March 2012; Accepted 5 March 2012

Academic Editor: E. Shevach

Copyright © 2012 Jozélio Freire de Carvalho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Favier, J. LeMaoult, N. Rouas-Freiss, P. Moreau, C. Menier, and E. D. Carosella, “Research on HLA-G: an update,” Tissue Antigens, vol. 69, no. 3, pp. 207–211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Kovats, E. K. Main, C. Librach, M. Stubblebine, S. J. Fisher, and R. Demars, “A class I antigen, HLA-G, expressed in human trophoblasts,” Science, vol. 248, no. 4952, pp. 220–223, 1990. View at Google Scholar · View at Scopus
  3. O. Baricordi, M. Stignani, L. Melchiorri, and R. Rizzo, “HLA-G and inflammatory diseases,” Inflammation and Allergy—Drug Targets, vol. 7, no. 2, pp. 67–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Wiendl, U. Feger, M. Mittelbronn et al., “Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity,” Brain, vol. 128, no. 11, pp. 2689–2704, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Verbruggen, V. Rebmann, C. Demanet, S. de Cock, and H. Grosse-Wilde, “Soluble HLA-G in Rheumatoid Arthritis,” Human Immunology, vol. 67, no. 8, pp. 561–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Rosado, G. Perez-Chacon, S. Mellor-Pita et al., “Expression of human leukocyte antigen-G in systemic lupus erythematosus,” Human Immunology, vol. 69, no. 1, pp. 9–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Rizzo, T. V. F. Hviid, M. Govoni et al., “HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus,” Tissue Antigens, vol. 71, no. 6, pp. 520–529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. W. A. Wilson, A. E. Gharavi, T. Koike et al., “International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop,” Arthritis & Rheumatism, vol. 42, no. 11, p. 1309, 1999. View at Google Scholar
  9. V. Rebmann, K. Pfeiffer, M. Päßler et al., “Detection of soluble HLA-G molecules in plasma and amniotic fluid,” Tissue Antigens, vol. 53, no. 1, pp. 14–22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Rebmann, K. van der Ven, M. Päßler, K. Pfeiffer, D. Krebs, and H. Grosse-Wilde, “Association of soluble HLA-G plasma levels with HLA-G alleles,” Tissue Antigens, vol. 57, no. 1, pp. 15–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Nigel Harris and S. Pierangeli, “The anticardiolipin ELISA test,” Clinical Immunology Newsletter, vol. 11, no. 3, pp. 33–44, 1991. View at Google Scholar · View at Scopus
  12. F. Wisloff, E. M. Jacobsen, and S. Liestol, “Laboratory diagnosis of the antiphospholipid syndrome,” Thrombosis Research, vol. 108, no. 71, p. 263, 2002. View at Google Scholar
  13. F. X. Wu, L. J. Wu, X. Y. Luo et al., “Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population.,” Lupus, vol. 18, no. 66, pp. 1259–1266, 2009. View at Google Scholar · View at Scopus
  14. H. Wiendl, L. Behrens, S. Maier, M. A. Johnson, E. H. Weiss, and R. Hohlfeld, “Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G,” Annals of Neurology, vol. 48, no. 84, p. 679, 2000. View at Google Scholar
  15. S. Aractingi, N. Briand, C. le Danff et al., “HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?” The American Journal of Pathology, vol. 159, no. 7, pp. 71–77, 2001. View at Google Scholar · View at Scopus
  16. M. I. Torres, M. le Discorde, P. Lorite et al., “Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease,” International Immunology, vol. 16, no. 4, pp. 579–583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. E. D. Carosella, P. Moreau, S. Aractingi, and N. Rouas-Freiss, “HLA-G: a shield against inflammatory aggression,” Trends in Immunology, vol. 22, no. 10, pp. 553–555, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Wiendl, M. Mitsdoerffer, and M. Weller, “Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathies,” Human Immunology, vol. 64, no. 11, pp. 1050–1056, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. T. D. Veit, E. A. A. Cordero, T. Mucenic et al., “Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus,” Lupus, vol. 18, no. 5, pp. 424–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. LeMaoult, I. Krawice-Radanne, J. Dausset, and E. D. Carosella, “HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 18, pp. 7064–7069, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. Verbruggen, V. Rebmann, C. Demanet, S. de Cock, and H. Grosse-Wilde, “Soluble HLA-G in rheumatoid arthritis,” Human Immunology, vol. 67, no. 8, pp. 561–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Baczyk, C. Dunk, B. Huppertz et al., “Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi,” Placenta, vol. 27, no. 4-5, pp. 367–374, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Menier, N. Rouas-Freiss, B. Favier, J. Lemaoult, P. Moreau, and E. D. Carosella, “Recent advances on the non-classical major histocompatibility complex class i HLA-G molecule,” Tissue Antigens, vol. 75, no. 3, pp. 201–206, 2010. View at Publisher · View at Google Scholar · View at Scopus